Navigation Links
Neurocrine Biosciences Announces Conference Call and Webcast to Present Second Quarter 2011 Financial Results
Date:7/21/2011

SAN DIEGO, July 21, 2011 /PRNewswire/ -- Neurocrine Biosciences, Inc. (Nasdaq: NBIX) announced today that the Company will report its second quarter 2011 financial results after the Nasdaq market closes on Thursday, July 28, 2011. Neurocrine will then host a live conference call and webcast to discuss its financial results and provide a Company update Friday morning, July 29, 2011 at 8:00 a.m. Eastern Time (5:00 a.m. Pacific Time).

Participants can access the live conference call by dialing 800-862-9098, (US) or 785-424-1051(International) using the conference ID: 7NBIX. The call can also be accessed via the webcast through the Company's website at http://www.neurocrine.com

If you are unable to attend the Webcast and would like further information on this announcement please contact the Investor Relations Department at Neurocrine Biosciences at (858) 617-7600. A replay of the Conference Call will be available approximately one hour after the conclusion of the call by dialing 800-283-8520(US) or 402-220-0870(International) using the conference ID: 7NBIX. The call will be archived for two weeks.

Neurocrine Biosciences, Inc. is a biopharmaceutical company focused on neurological and endocrine diseases and disorders. Our product candidates address some of the largest pharmaceutical markets in the world, including endometriosis, stress-related disorders, pain, diabetes, insomnia, and other neurological and endocrine-related diseases and disorders. Neurocrine Biosciences, Inc. news releases are available through the Company's website via the internet at http://www.neurocrine.com


'/>"/>
SOURCE Neurocrine Biosciences, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1

Related medicine technology :

1. Neurocrine Biosciences Announces elagolix Scientific Presentations at the 11th World Congress on Endometriosis
2. Neurocrine Biosciences to Present at the Jefferies 2011 Global Healthcare Conference
3. Neurocrine Biosciences to Present at the Deutsche Bank 36th Annual Healthcare Conference
4. Neurocrine Biosciences to Present at the 10th Annual Needham Healthcare Conference
5. Neurocrine Biosciences to Present at the Roth 23rd Annual OC Growth Stock Conference
6. Neurocrine Biosciences to Present at Citis 2011 Global Health Care Conference
7. Neurocrine Biosciences Announces Conference Call and Webcast to Present Fourth Quarter and Year-End 2010 Financial Results
8. Neurocrine Biosciences Reports Third Quarter 2010 Results
9. Neurocrine Biosciences to Present at the Oppenheimer 21st Annual Healthcare Conference
10. Neurocrine Announces Top-Line Results of Corticotropin Releasing Factor Antagonist GSK561679 for Treatment of Major Depressive Disorder
11. Neurocrine Biosciences Announces Conference Call and Webcast to Report Second Quarter 2010 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2017)... 4, 2017  DarioHealth Corp. (NASDAQ: DRIO), a leading ... data solutions, today announced that it is teaming up ... Technologies Limited to lower diabetes healthcare costs in ... card, which is available throughout all provinces and territories ... be eligible for additional savings when shopping for Dario ...
(Date:5/3/2017)... COUNTY, Calif. , May 3, 2017 /PRNewswire/ ... aspect of any hospital or healthcare facility. Commonly ... examination room is equipped with diagnostic imaging technology ... arteries of the heart. In these spaces, a ... angiography, catheterization, balloon angioplasty, percutaneous coronary intervention, congenital ...
(Date:5/3/2017)... Pa. , May 3, 2017  West ... in innovative solutions for injectable drug administration, announced ... Scientific Affairs and Technical Services, and Diane ... workshops and offering presentations focused on West,s expertise ... injectable products, as well as providing commentary on ...
Breaking Medicine Technology:
(Date:5/19/2017)... ... May 19, 2017 , ... As a groundbreaking surgeon on ... importance of prostate cancer screenings. Early detection of the disease, he says, can make ... at Georgia Urology , stands alongside the Georgia Comprehensive Cancer Control’s (GC3) Prostate ...
(Date:5/19/2017)... ... , ... CloSYS products which are marketed as the gentle giants of the ... gum health, which is linked to one’s overall health. Since 1991 when the CloSYS ... ways in which CloSYS products immediately helped eliminate bad breath as well as help ...
(Date:5/19/2017)... Santa Clara, CA (PRWEB) , ... May 18, 2017 , ... ... feature that allows sleep labs and physicians to independently dispense CPAP devices and supplies, ... DME orders, and sleep labs can dispense the devices. Device registration for daily usage ...
(Date:5/18/2017)... ... May 18, 2017 , ... Originally launched to market as the EPIK ... Due to the rapid expansion of their product line, the company believed it was ... Now, the HighQ brand will be any tablet product sold by EPIK Learning. ...
(Date:5/18/2017)... (PRWEB) , ... May 18, 2017 , ... ... Alliance, a Dulles, VA based educational and charitable organization which sponsors numerous programs ... for their third MURPH Challenge event over Memorial Day Weekend. , The ...
Breaking Medicine News(10 mins):